As of 2026-10-18, the Fair Value of Kura Oncology Inc (KURA) is -16.72 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 9.08 USD, the upside of Kura Oncology Inc is -284.10%.
With the market price of 9.08 USD and our fair value calculation, Kura Oncology Inc (KURA) is not a good investment. Investing in KURA stocks now will result in a potential loss of 284.10%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | 5Y Avg | |
| Net income | -130.47 | -135.84 | -152.63 | -173.98 | -278.67 | -174.32 |
| YoY growth | -45.57% | -4.12% | -12.36% | -13.99% | -60.17% | -27.24% |
| Market Cap (mil) | 806.03 |
| P/E | |
| Forward P/E |
| EPS | -3.34 |
| Avg earnings growth rate | -27.24% |
| TTM earnings | -296.77 |